A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.

@article{Reitamo2008A4F,
  title={A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.},
  author={Sakari Reitamo and Malcolm H. A. Rustin and John Harper and Kirsti Kalimo and Andris Rubins and Frederic Cambazard and Elian E A Brenninkmeijer and Catherine Smith and John Berth-Jones and Thomas Ruzicka and Graham Sharpe and Alain Taieb},
  journal={The British journal of dermatology},
  year={2008},
  volume={159 4},
  pages={942-51}
}
BACKGROUND For the treatment of a chronic disease like atopic dermatitis, sustained tolerability and efficacy of the applied medication are essential. OBJECTIVES The present open-label, noncomparative study was conducted to obtain information on the long-term safety and efficacy of 0.1% tacrolimus ointment. METHODS Patients aged 2 years or older with an affected body surface area of more than 5%, who previously participated in a clinical trial on tacrolimus ointment, were eligible for this… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

Journal of the European Academy of Dermatology and Venereology : JEADV • 2012

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

Journal of the European Academy of Dermatology and Venereology : JEADV • 2012

References

Publications referenced by this paper.
Showing 1-10 of 40 references

The black box warning for topical calcineurin inhibitors: looking outside the box.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2006

Efficacy and safety of tacroli

S Reitamo, EJM van Leent, V Ho
dermatitis. Br J Dermatol • 2005

Similar Papers

Loading similar papers…